Loading...

Brilliant Violet 605™ anti-mouse CD62L Antibody

Pricing & Availability
Clone
MEL-14 (See other available formats)
Regulatory Status
RUO
Other Names
L-selectin, LECAM-1, Ly-22, LAM-1, MEL-14
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEL-14_BV605_020312
C57BL/6 mouse splenocytes cells were stained with CD62L (clone MEL-14) Brilliant Violet 605™.
  • MEL-14_BV605_020312
    C57BL/6 mouse splenocytes cells were stained with CD62L (clone MEL-14) Brilliant Violet 605™.
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Quantity Check Availability Save
104437 125 µL 199€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104438 50 µg 219€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD62L is a 74-95 kD glycoprotein also known as L-selectin, LECAM-1, Ly-22, LAM-1, and MEL-14. It is a member of the selectin family and is expressed on the majority of B and naïve T cells, a subset of memory T cells, monocytes, granulocytes, most thymocytes, and a subset of NK cells. CD62L is important in lymphocyte homing to high endothelial venules (HEV) in peripheral lymph nodes and leukocyte "rolling" on activated endothelium. CD62L also contributes to neutrophil emigration at inflammatory sites. CD62L is rapidly shed from lymphocytes and neutrophils upon cellular activation and the expression levels of CD62L (in conjunction with other markers) have been used to distinguish naïve, effector, and memory T cells. CD62L has been reported to interact with CD34, GlyCAM-1, and MAdCAM-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. For immunofluorescent staining using the µl size, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Barkaway A, et al. 2021. Immunity. . PubMed
  2. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  3. Wang D, et al. 2018. Immunity. 48:659. PubMed
  4. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  5. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  6. Dong L, et al. 2021. Cancer Cell. . PubMed
  7. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  8. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  9. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  10. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  11. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  12. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  13. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  14. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  15. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  16. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  17. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  18. Pérol L, et al. 2016. Nat Commun. 7:13027. PubMed
  19. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  20. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  21. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  22. Gagnon JD, et al. 2019. Cell Rep. 28:2169. PubMed
  23. Beura LK, et al. 2018. Immunity. 48:327. PubMed
  24. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  25. Loo CS, et al. 2020. Immunity. 53:143. PubMed
  26. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  27. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  28. Montalban-Arques A, et al. 2021. Cell Host Microbe. :. PubMed
  29. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  30. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  31. Korin B, et al. 2020. Sleep. :43. PubMed
  32. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  33. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  34. Chiou NT et al. 2018. Cell reports. 25(12):3356-3370 . PubMed
  35. D’Amico L, et al. 2016. J Exp Med. 213: 827 - 840. PubMed
  36. Cobbold SP, et al. 2018. Front Immunol. 9:1381. PubMed
  37. Gutierrez D, et al. 2014. Diabetes. 63:3827. PubMed
RRID
AB_11125577 (BioLegend Cat. No. 104437)
AB_2563058 (BioLegend Cat. No. 104438)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account